Sequent Scientific Limited (BOM: 512529)

Market Cap	43.03B
Revenue (ttm)	14.27B
Net Income (ttm)	54.91M
Shares Out	249.17M
EPS (ttm)	0.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	177,007
Open	176.00
Previous Close	176.00
Day's Range	176.00 - 184.65
52-Week Range	86.03 - 184.65
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2024

About Sequent Scientific

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology fo...

• Industry: Pharmaceutical Preparations
• Founded: 1985
• Employees: 1,195
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 512529

Financial Performance

In 2023, Sequent Scientific's revenue was 13.70 billion, a decrease of -3.60% compared to the previous year's 14.21 billion. Losses were -358.69 million, -70.40% less than in 2022.